Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

CVS Group sees earnings ahead of expectations

Published 20/07/2021, 10:54
Updated 20/07/2021, 10:56
© Reuters

© Reuters

By Samuel Indyk

Investing.com – Shares in veterinary service provider CVS Group (LON:CVSG) were trading higher on Tuesday following a trading update. The company said like-for-lake sales increased 17.4% in the full year, accelerating in the final quarter given that the comparative quarter last year was impacted by Covid-19 restrictions.

The company now expects to report adjusted EBITDA for FY21 marginally ahead of market expectations as upgraded following a trading update in April.

“While there was some disruption to service because of restrictions, on the whole CVS Group’s vet clinics fared much better than other businesses,” writes Hargreaves Lansdown (LON:HRGV) Senior Equity Analyst Sophie Lund-Yates in an emailed note.

“As restrictions have allowed clinics to offer a wider range of treatments once more, business has boomed, allowing full year profit expectations to be upgraded yet again.”

Outlook

The veterinary practice said it is also well placed to pursue further targeted acquisitions and plans to improve its level of clinical care through investment in people and specialist facilities.

There can be no doubt the CVS has benefitted from an increase in pet ownership among UK households since the pandemic began.

“CVS Group is also likely being buoyed by the phenomenal rise in pet ownership brought about during lockdowns, which should act as a long-term boon,” Lund-Yates said.

“CVS Group’s revenues are particularly attractive, because once a pet owner registers an animal with a clinic, they’re very likely to be a repeat customer over its lifetime.

“Recurring revenues are somewhat of a luxury in the world of business, adding a layer of certainty others could only hope for.”

At 10:45BST, shares in CVS Group were trading flat at 2,260 pence per share.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.